Applied Dna Sciences earnings were -$67.5M for the trailing 12 months ending Jun 30, 2025, with N/A growth year over year. The latest APDN earnings report on Jun 30, 2025 announced Q2 2025 earnings of -$19.4M, down 28.6% from last quarter. For the last reported fiscal year 2024 ending Sep 30, 2024, APDN reported annual earnings of -$7.2M, with -27.4% growth.
Applied Dna Sciences Earnings Reports & History FAQ
What were Applied Dna Sciences's earnings last quarter?
Applied Dna Sciences (NASDAQ: APDN) reported Q2 2025 earnings per share (EPS) of -$34.00, up 102.9% year over year. Total APDN earnings for the quarter were -$19.45 million. In the same quarter last year, Applied Dna Sciences's earnings per share (EPS) was $1,170.48.
Is Applied Dna Sciences profitable or losing money?
As of the last Applied Dna Sciences earnings report, Applied Dna Sciences is currently losing money. Applied Dna Sciences's net profit (also called net income) for the twelve months ending Jun 30, 2025 was -$13.19 million, a 80.92% increase year over year.
What was APDN's earnings growth in the past year?
As of Applied Dna Sciences's earnings date in Q3 2025, Applied Dna Sciences's earnings has grown year over year. APDN earnings in the past year totalled -$67.51 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.